ArticleTranslational cancer research2025

FBXO5 drives hepatocellular carcinoma progression and is a target for tea polyphenol-mediated inhibition.

Xinyu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.